{"filing":{"accession_number":"0001193125-26-335150","cik":"0001111485","ticker":"RXST","company_name":"RxSight, Inc.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"rxst-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1111485/000119312526335150/rxst-20260805.htm"},"events":[{"id":24758,"run_id":22445,"accession_number":"0001193125-26-335150","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"RxSight issued a press release on August 5, 2026 announcing its financial results for the three months ended June 30, 2026, including total revenue of $33.7 million, product sales of $27.2 million (down 19% year-over-year), and a net loss of $(12.1) million. The filing explicitly states under Item 2.02 that the company \"issued a press release announcing its results of operations and financial condition\" with the press release attached as Exhibit 99.1. This is a standard quarterly earnings disclosure.","company_name":"RxSight, Inc.","ticker":"RXST","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":25423,"accession_number":"0001193125-26-335150","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"RxSight issued a press release on August 5, 2026 announcing its financial results for the three months ended June 30, 2026, including total revenue of $33.7 million, product sales of $27.2 million (down 19% year-over-year), and a net loss of $(12.1) million. The filing explicitly states under Item 2.02 that the company \"issued a press release announcing its results of operations and financial condition\" with the press release attached as Exhibit 99.1. This is a standard quarterly earnings disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:19:33.181988+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25423,"accession_number":"0001193125-26-335150","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"RxSight issued a press release on August 5, 2026 announcing its financial results for the three months ended June 30, 2026, including total revenue of $33.7 million, product sales of $27.2 million (down 19% year-over-year), and a net loss of $(12.1) million. The filing explicitly states under Item 2.02 that the company \"issued a press release announcing its results of operations and financial condition\" with the press release attached as Exhibit 99.1. This is a standard quarterly earnings disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:19:33.181988+00:00","company_name":"RxSight, Inc.","ticker":"RXST","filing_date":"2026-08-05"}]}